Hims & Hers Health, Inc. (NYSE: HIMS) Securities Fraud Investigation

HIMS Sued By the Federal Trade Commission
On July 29, 2026, the Federal Trade Commission (“FTC”) filed a lawsuit against HIMS accusing the company of sharing customers’ medical information with third-party advertisers. Specifically,
the FTC’s criminal complaint accuses HIMS of “deceptive and unlawful privacy practices,” including sharing sensitive details about a patient’s health with Snap and Facebook parent, Meta Platforms.

HIMS’s Stock Drops Over 14%
Following the news of the FTC’s lawsuit, Hims & Hers Health, Inc.’s stock price fell over 14%.

If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP:  Jonathan Naji, Esq. (484) 270-1453 or via e-mail at [email protected].  

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP: 
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent.